Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in September - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended in September. The mean
expectation of eight analysts for the quarter was for a loss
of 25 cents per share.
    * Revenue rose 25.2% to $75.59 million from a year ago;
analysts
expected $66.44 million. 
    * Veracyte Inc's reported EPS for the quarter was a loss
of 12
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3% in
the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Veracyte Inc shares had risen by 24.4% this quarter and
lost 49.9% so far this year.
    * The company reported a quarterly loss of $8.72 million.
    * Wall Street's median 12-month price target for Veracyte
Inc is
$30.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
2 at 09:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.25          -0.12          Beat
 Jun. 30 2022      -0.22          -0.13          Beat
 Mar. 31 2022      -0.24          -0.20          Beat
 Dec. 31 2021      -0.16          -0.15          Beat

Recent news on Veracyte

See all news